Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Design and validation of anti-inflammatory peptides from human parotid secretory protein.

Geetha C, Venkatesh SG, Bingle L, Bingle CD, Gorr SU.

J Dent Res. 2005 Feb;84(2):149-53.

PMID:
15668332
2.

The BSP30 salivary proteins from cattle, LUNX/PLUNC and von Ebner's minor salivary gland protein are members of the PSP/LBP superfamily of proteins.

Wheeler TT, Haigh BJ, McCracken JY, Wilkins RJ, Morris CA, Grigor MR.

Biochim Biophys Acta. 2002 Dec 12;1579(2-3):92-100.

PMID:
12427544
3.

Human parotid secretory protein is a lipopolysaccharide-binding protein: identification of an anti-inflammatory peptide domain.

Abdolhosseini M, Sotsky JB, Shelar AP, Joyce PB, Gorr SU.

Mol Cell Biochem. 2012 Jan;359(1-2):1-8. doi: 10.1007/s11010-011-0991-2. Epub 2011 Jul 16.

4.
5.
6.
7.

Bovine parotid secretory protein: structure, expression and relatedness to other BPI (bactericidal/permeability-increasing protein)-like proteins.

Wheeler TT, Hood K, Oden K, McCracken J, Morris CA.

Biochem Soc Trans. 2003 Aug;31(Pt 4):781-4. Review.

PMID:
12887305
8.

Expression and anti-bacterial activity of human parotid secretory protein (PSP).

Geetha C, Venkatesh SG, Dunn BH, Gorr SU.

Biochem Soc Trans. 2003 Aug;31(Pt 4):815-8.

PMID:
12887312
9.

Design of bacteria-agglutinating peptides derived from parotid secretory protein, a member of the bactericidal/permeability increasing-like protein family.

Gorr SU, Sotsky JB, Shelar AP, Demuth DR.

Peptides. 2008 Dec;29(12):2118-27. doi: 10.1016/j.peptides.2008.09.019. Epub 2008 Oct 5.

PMID:
18952131
10.

Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.

Battafaraono RJ, Dahlberg PS, Ratz CA, Johnston JW, Gray BH, Haseman JR, Mayo KH, Dunn DL.

Surgery. 1995 Aug;118(2):318-24.

PMID:
7638748
11.

Dual host-defence functions of SPLUNC2/PSP and synthetic peptides derived from the protein.

Gorr SU, Abdolhosseini M, Shelar A, Sotsky J.

Biochem Soc Trans. 2011 Aug;39(4):1028-32. doi: 10.1042/BST0391028. Review.

12.

Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation.

Wilde CG, Seilhamer JJ, McGrogan M, Ashton N, Snable JL, Lane JC, Leong SR, Thornton MB, Miller KL, Scott RW, et al.

J Biol Chem. 1994 Jul 1;269(26):17411-6.

13.

Design of a potent novel endotoxin antagonist.

Uknis ME, Wasiluk KR, Acton RD, Klaerner HG, Dahlberg PS, Ilyina EE, Haseman JR, Gray BH, Mayo KH, Dunn DL.

Surgery. 1997 Aug;122(2):380-5.

PMID:
9288144
14.
16.

A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.

Dahlberg PS, Acton RD, Battafarano RJ, Uknis ME, Ratz CA, Johnston JW, Haseman JR, Gray BH, Dunn DL.

J Surg Res. 1996 Jun;63(1):44-8.

PMID:
8661170
17.

Expansion of the Bactericidal/Permeability Increasing-like (BPI-like) protein locus in cattle.

Wheeler TT, Hood KA, Maqbool NJ, McEwan JC, Bingle CD, Zhao S.

BMC Genomics. 2007 Mar 15;8:75.

18.

Comparative analysis of the PLUNC (palate, lung and nasal epithelium clone) protein families.

Bingle CD, Craven CJ.

Biochem Soc Trans. 2003 Aug;31(Pt 4):806-9. Review.

PMID:
12887310
19.

Characterisation and expression of SPLUNC2, the human orthologue of rodent parotid secretory protein.

Bingle L, Barnes FA, Lunn H, Musa M, Webster S, Douglas CW, Cross SS, High AS, Bingle CD.

Histochem Cell Biol. 2009 Sep;132(3):339-49. doi: 10.1007/s00418-009-0610-4. Epub 2009 Jun 5.

PMID:
19499239
20.

Evidence of a bactericidal permeability increasing protein in an invertebrate, the Crassostrea gigas Cg-BPI.

Gonzalez M, Gueguen Y, Destoumieux-Garzón D, Romestand B, Fievet J, Pugnière M, Roquet F, Escoubas JM, Vandenbulcke F, Levy O, Sauné L, Bulet P, Bachère E.

Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17759-64. Epub 2007 Oct 26.

Supplemental Content

Support Center